Disclaimer: MercyIowaCityClinics.org is an independent editorial publication and is not affiliated with any hospital, clinic, or medical provider. Statements about dietary supplements have not been evaluated by the Food and Drug Administration. Products discussed are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare professional before starting any supplement, particularly if you take prescription medications.
Most Memoryl reviews cite the same eight ingredients from the brand's own PR materials. The MICC Review Team verified the actual product label, which contains ten. The full formula — including L-Tyrosine and Rhodiola, absent from every piece of brand-produced content the MICC Review Team examined — is what gets analyzed here. Per-ingredient dosages are not publicly disclosed on Memopryl's accessible web pages; the research dosages referenced below reflect the doses used in published clinical trials, not confirmed Memopryl serving amounts. Whether Memopryl's two-capsule serving delivers each ingredient at research-relevant levels requires verification from the physical label.
This is not a marketing article. Every claim below is supported by peer-reviewed sources or explicitly labeled as a mechanistic background or preliminary. The goal is to give you what no affiliate review in this SERP provides: an honest read of what the science actually shows, at what doses, in what populations, with what limitations.
Bacopa Monnieri — The Strongest Evidence in This Formula
Bacopa Monnieri is an Ayurvedic botanical whose active compounds, the bacosides, have been examined in multiple double-blind, randomized controlled trials for effects on memory in healthy adults. This is the most credibly supported ingredient in the Memopryl formula for the product's primary use case.
A 2001 double-blind trial published in Psychopharmacology by Roodenrys and colleagues examined 300mg of Bacopa Monnieri extract in healthy adults over 12 weeks and found significant improvements in verbal learning rate and memory consolidation compared to placebo. A 2008 study in the Journal of Alternative and Complementary Medicine by Calabrese and colleagues found improvements in working memory and attention in healthy older adults at 300mg over 12 weeks. A systematic review published in the Journal of Ethnopharmacology in 2014 examined nine randomized controlled trials and concluded that Bacopa Monnieri improved speed of attention and working memory compared to placebo, with the authors noting that the evidence, while promising, requires further replication.
The consistent finding across these trials: effects emerge after 8 to 12 weeks of continuous supplementation. Bacopa Monnieri does not produce acute cognitive enhancement. Buyers expecting to feel a difference within days are misreading the research. The proposed mechanism involves bacoside-mediated upregulation of antioxidant enzymes in the hippocampus, modulation of the serotonin and acetylcholine systems, and promotion of synaptic repair — all processes that operate over weeks, not hours. Research dosages cluster in the 300-450mg range for a standardized extract. Memopryl's two-capsule serving must contain Bacopa Monnieri in this range to align with the evidence base, and buyers cannot verify this without the physical label.
Alpha-GPC — Cholinergic Support With a Dosage Transparency Problem
Alpha-GPC (Alpha Glycerophosphorylcholine) is a choline compound and direct precursor to acetylcholine, the neurotransmitter central to memory encoding, learning, and attention. The body converts Alpha-GPC into choline, which, in turn, supports acetylcholine synthesis in the brain. This is the first half of Memopryl's cholinergic system design — the second half is Huperzine-A, which prevents acetylcholine from being broken down.
The clinical evidence on Alpha-GPC is most robust in populations with cognitive decline. A 1991 multicenter Italian trial and subsequent work published in journals including Clinical Therapeutics and Aging found significant improvements on memory and cognitive function measures in patients with mild-to-moderate Alzheimer's disease at 400mg three times daily (1,200mg total). Research in healthy adults is more limited, with smaller trials showing improvements in reaction time and attention at lower doses.
The transparency concern specific to Memopryl: the clinically studied doses for Alpha-GPC are high relative to what fits in a two-capsule nootropic blend alongside nine other ingredients. Distributing 10 ingredients across two standard capsules (roughly 700mg to 1,000mg total capacity depending on capsule size) makes it mathematically impossible to include several ingredients at their full clinical research doses simultaneously. This is the standard limitation of multi-ingredient nootropic stacks and is not unique to Memopryl — but it is why per-ingredient dosage disclosure matters, and why its absence is a legitimate buyer concern rather than a minor detail.
Huperzine-A — Mechanistically Coherent, Medically Significant
Huperzine-A is derived from the Chinese club moss Huperzia serrata and functions as a reversible acetylcholinesterase inhibitor — it blocks the enzyme responsible for breaking down acetylcholine in synaptic clefts, extending neurotransmitter availability. This is the same molecular target as the prescription Alzheimer's medications donepezil, rivastigmine, and galantamine.
Research on Huperzine-A includes several Chinese randomized controlled trials examining its effects on memory in both healthy students and patients with Alzheimer's disease or vascular dementia. A 1999 trial in Acta Pharmacologica Sinica found improvements in memory and learning performance in middle school students at 100mcg twice daily. Results from Alzheimer's populations have shown improvements in cognitive function in several trials, though the evidence base is considered preliminary by Western systematic review standards due to concerns about trial quality and publication bias.
Effective doses in research range from 50 mcg to 200 mcg daily — small quantities that should be achievable in a multi-ingredient blend. The interaction profile with prescription cholinesterase inhibitors is the primary safety concern and is covered in detail in the Memopryl side effects and interactions article.
Phosphatidylserine — The FDA Qualified Health Claim Ingredient
Phosphatidylserine is a phospholipid that constitutes a significant portion of brain cell membranes and plays a role in cell-to-cell signaling and neurotransmitter release. It is the only ingredient in Memopryl for which the FDA has issued a qualified health claim — a designation below a full health claim that acknowledges limited but credible evidence for a specific health benefit.
The FDA's qualified claim, issued in 2003, states that phosphatidylserine “may reduce the risk of dementia and cognitive dysfunction in the elderly” with the caveat that “the evidence is limited and not conclusive.” Earlier research used soy-derived phosphatidylserine; more recent studies have used plant-derived forms. A 2010 randomized controlled trial in the Journal of Clinical Biochemistry and Nutrition found improvements in memory scores in elderly subjects with memory complaints after 6 months of supplementation at 300mg daily. Research dosages for cognitive effects cluster around 300mg to 400mg daily. Phosphatidylserine has a well-established safety profile and minimal drug interaction concerns.
L-Tyrosine — The Undisclosed Stress Buffer
L-Tyrosine is an amino acid and precursor to catecholamine neurotransmitters, including dopamine, norepinephrine, and epinephrine. It does not appear in any Memoryl-branded PR material or affiliate ecosystem content that the MICC Review Team has found — its presence on the verified label is one of the two significant discrepancies between brand communications and the actual formula.
The research on L-Tyrosine focuses primarily on acute maintenance of cognitive performance under stress and deprivation conditions rather than on long-term memory enhancement. A 1999 study in the journal Nutritional Neuroscience found that L-Tyrosine supplementation attenuated the decline in working memory and psychomotor performance associated with cold stress and sleep deprivation. Research has also examined L-Tyrosine for maintaining cognitive performance during military operations and demanding occupational conditions, with consistent findings that it buffers stress-induced cognitive decline. The proposed mechanism involves replenishing catecholamine stores depleted during high-stress demands — a distinct functional role from the memory consolidation pathway supported by Bacopa Monnieri and Phosphatidylserine.
Research doses range from 100mg per kilogram of body weight in acute stress studies to more modest amounts in daily supplementation contexts. L-Tyrosine is generally well tolerated, though it is contraindicated in individuals taking MAO inhibitors.
Rhodiola Rosea — The Second Undisclosed Ingredient
Rhodiola Rosea is an adaptogenic botanical native to Arctic and alpine regions, studied primarily for its effects on mental fatigue, stress resilience, and mood. Like L-Tyrosine, Rhodiola is present on the verified Memopryl label but absent from every piece of brand-produced content the MICC Review Team has accessed.
A 2000 randomized double-blind trial published in Phytomedicine by Darbinyan and colleagues examined Rhodiola SHR-5 extract in physicians on night duty and found significant reductions in fatigue and improvements in cognitive performance including associative thinking, short-term memory, and concentration on a standardized test battery. A 2007 trial by Shevtsov and colleagues in Phytomedicine found similar results in young military cadets under stress. The active compounds — rosavins and salidrosides — are proposed to act by modulating cortisol, serotonin, and beta-endorphin systems, as well as inhibiting MAO enzymes at higher doses.
The MAO inhibition activity at high doses is a relevant interaction consideration — see the Memopryl side effects and interactions article for the full profile. Standardized extracts of Rhodiola have been used at 200-600mg in research, with effects on acute mental fatigue observed at the lower end of this range.
N-Acetyl-L-Carnitine — Mitochondrial Support for Brain Cells
N-Acetyl-L-Carnitine (ALCAR) is the acetylated form of L-Carnitine, an amino acid derivative involved in transporting long-chain fatty acids into mitochondria for energy production. In the brain, ALCAR plays a role in maintaining mitochondrial function in neurons — a housekeeping process that becomes relevant in aging, when neuronal energy metabolism declines. ALCAR also has some acetylcholine-related activity via its acetyl group.
Clinical trials on N-Acetyl-L-Carnitine for cognitive health have been conducted primarily in older adults and in Alzheimer's populations. A 1991 meta-analysis in Neurobiology of Aging examining multiple double-blind trials found that ALCAR showed significantly better outcomes than placebo on measures of cognitive function in patients with Alzheimer's disease. A 1995 multicenter double-blind trial in Neurology showed benefits specifically in patients under 66 with early-onset Alzheimer's. Research in healthy adults without cognitive impairment is more limited. Research doses have ranged from 1,500mg to 3,000mg daily — substantially higher than what is feasible in a two-capsule blend alongside nine other ingredients.
Ginkgo Biloba — Extensively Studied, Modestly Effective in Healthy Adults
Ginkgo Biloba is among the most researched botanical extracts in cognitive health literature, with decades of trials examining its flavonoid and terpenoid compounds for effects on memory and cerebral circulation. The honest summary of that literature in healthy adults is: effects exist but are modest and inconsistent.
A 2002 Cochrane review of 33 trials concluded there was “promising evidence” of improvement in cognition and function associated with Ginkgo Biloba, particularly in dementia. A 2009 randomized controlled trial in JAMA by DeKosky and colleagues — one of the largest nootropic trials ever conducted, involving over 3,000 elderly participants over approximately 6 years — found that Ginkgo Biloba did not reduce the incidence of Alzheimer's dementia or slow cognitive decline compared to placebo. Research in healthy younger adults has shown effects on memory speed and working memory in some trials at 120mg to 240mg of standardized extract (24% flavone glycosides). The weight of evidence does not support Ginkgo Biloba as a meaningful cognitive enhancer in cognitively healthy adults, though its circulatory and antioxidant mechanisms are well-established.
L-Glutamine — Foundational Neurotransmitter Precursor
L-Glutamine is the most abundant free amino acid in the bloodstream and a precursor to both glutamate (the brain's primary excitatory neurotransmitter) and GABA (the primary inhibitory neurotransmitter). In the context of a nootropic formula, it provides substrate for neurotransmitter synthesis rather than a specific cognitive enhancement mechanism. Research on L-Glutamine supplementation for cognitive enhancement in healthy adults is limited. Its inclusion in multi-ingredient nootropic formulas is common and reflects foundational brain support rather than a targeted effect on memory or focus.
St. John's Wort — The Drug Interaction Ingredient
St. John's Wort (Hypericum perforatum) has a documented research record for mood support, with multiple trials supporting its use for mild-to-moderate depression at doses of 300mg of standardized extract (0.3% hypericin) three times daily. Several meta-analyses have found it comparable to low-dose antidepressants for mild depression with fewer side effects in short-term use.
Its primary significance in the context of Memopryl — a supplement positioned for cognitive support rather than mood — is its drug interaction profile, which is the most clinically significant of any ingredient in this formula. St. John's Wort is a potent inducer of CYP450 enzymes (specifically CYP3A4, CYP2C9) and P-glycoprotein, affecting the metabolism of a broad range of drugs. This is covered in full in the Memopryl side effects and interactions article. The short version: if you take any prescription medication, discuss St. John's Wort specifically with your prescribing physician before starting this formula.
The Research Summary: What This Formula Can and Cannot Claim
Memopryl's 10 ingredients include several compounds with robust research records — Bacopa Monnieri, Phosphatidylserine, and the Alpha-GPC/Huperzine-A cholinergic pairing — that reflect the most studied approaches in cognitive support supplementation. The undisclosed inclusion of L-Tyrosine and Rhodiola adds a stress-resilience and mental fatigue dimension that the brand's own marketing does not communicate. The formula is more complete than the brand describes it.
The honest limitations hold: no clinical trial of the finished Memopryl formula has been published. Per-ingredient dosages are not publicly accessible for independent verification. The most relevant research on several ingredients (Alpha-GPC, N-Acetyl-L-Carnitine) was conducted at doses that exceed what a two-capsule supplement can realistically deliver simultaneously. Drug interaction concerns — primarily St. John's Wort and Huperzine-A — require medical consultation for specific populations.
For background on how DSHEA supplement regulation works and what to evaluate before purchasing any nootropic, see What Is Memopryl. For the full buyer evaluation including pricing, refund policy, and the MICC verdict on overall value, see the complete Memopryl review. For context on how this formula compares to alternatives that disclose per-ingredient dosages, see Memopryl vs. nootropic supplements.
MercyIowaCityClinics.org is an independent editorial publication. This article does not constitute medical advice. Always consult a qualified healthcare professional before starting any supplement.